Purchase Order W81K0024P0152
Award Date
10/1/24
Potential Completion Date
9/30/29
Potential Value
$384K
Federal Agency
Medical Command
Awardee
Alba Bioscience, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, involves the delivery of Red Blood Cell (RBC) Reagents. The contract, valued at $78,678.95, was awarded by the Defense Health Agency and has an ultimate completion date of November 30, 2027. The contract was issued as a Delivery Order under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, and is a Firm Fixed Price arrangement. Alba Bioscience is a leading supplier of specialized...
This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the supply of specialized in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, valued at $6,750.00, was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to support defense medical operations. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV), likely a Blanket Purchase Agreement...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The $1,118.00 Firm Fixed Price Delivery Order (SPE2DE22D0008|SPE2D625F38A1) is for the product "ALBACLONE ANTI-A" and has an ultimate completion date of December...
This federal contract award to Alba Bioscience, Inc. is for the delivery of blood bank reagents, including products such as ALBACYTE antibody screening cells, ALBACLONE antibodies, ALBAHANCE additives, and ALBASURE quality control kits. The contract has a ceiling value of $81,733.18 and a period of performance from April 1, 2019 to April 1, 2020. Alba Bioscience, Inc. is a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and...
This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, was issued by the Defense Health Agency (DHA). The $54,873.00 firm fixed-price delivery order is for the provision of specialized blood banking products, including ALBACYTE A1 cells, ALBACYTE B cells, ALBACYTE IgG sensitized cells, and ALBACYTE antibody screen (3-cells), under the General Services Administration (GSA) Schedule 65-VII for in vitro diagnostics, reagents, and tests. The contract has a...
This is a federal contract award to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract, valued at $4,886.95, is a delivery order issued by the Defense Logistics Agency Troop Support Medical for the supply of ALBACLONE Anti-S (Big S) blood bank products. The contract has a firm fixed-price pricing type and...
The U.S. Defense Health Agency awarded a $45,602.75 firm-fixed-price purchase order contract to Alba Bioscience, Inc., a foreign-owned for-profit organization, for the delivery of ALBACTYE screening cells antibody. The contract has an ultimate completion date of September 30, 2028 and was not set aside for a specific business type. Alba Bioscience, a subsidiary of Quotient Biodiagnostics, Inc., is a leading supplier of specialized biomedical products and services primarily supporting blood...
This federal contract award, valued at $1,239.00, was made to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, awarded by the Defense Logistics Agency's Medical Supply Chain division, is for the delivery of ALBACYTE antibody screening cells, a critical product used in blood banking operations across various government agencies, including...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned for-profit organization, for the provision of ALBACLONE ANTI-A medical supplies. The contract has a ceiling value of $1,123.00 and a period of performance through April 4, 2024. It is a firm fixed price contract, and there was no set-aside designation used. Alba Bioscience, Inc. is a leading provider of specialized in vitro diagnostics and blood bank reagents, and this...
This federal contract award, valued at $2,378.29, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract is a delivery order for the ALBACYTE Antibody Screen (3-cell), a critical blood banking product used to support medical operations...